@Insmed

We're a global biopharmaceutical company striving to transform the lives of patients facing serious diseases. Community guidelines: https://xitter.cf/t.co/Mxp3SAUmXs

 Bridgewater, NJ
insmed.com/
Joined April 2019
  • Tweets802
  • Following77
  • Followers2K
715Media
We’re looking forward to joining the conversation at #CHEST2026 and #IDWeek2026, sharing data that advances understanding of respiratory disease. Learn more: bit.ly/4c5hLJb
1
194
The @FDA has granted Priority Review to our supplemental New Drug Application (sNDA) for our Mycobacterium avium complex (MAC) lung disease therapy, with a target action date of January 28, 2027. Read more: bit.ly/4c5hLJb
1
7
1,157
We’re heading to the #ERSCongress 2026 to share the latest research updates from across our respiratory pipeline. Learn more: investor.insmed.com/releases
Insmed to attend the ERS Congress 2026.

ALT Insmed to attend the ERS Congress 2026.

242
Join us at the 12th Annual Cantor Fitzgerald Global Healthcare Conference and the @MorganStanley 24th Annual Global Healthcare Conference to hear about our progress, strategic priorities, and the evolving healthcare landscape. $INSM
1
288
Japan's Ministry of Health, Labour and Welfare has approved our therapy as the first and only treatment in Japan for non-cystic fibrosis bronchiectasis (NCFB) in patients 12 years of age and older. Learn more: bit.ly/4c5hLJb
2
3
307
We’re sharing our Q2 2026 earnings results today. Watch below for key highlights and read more here: bit.ly/3RS4L2w $INSM
1
420
At Insmed, everything we do starts and ends with patients. Today, we shared positive 12-Month data from our ongoing open-label extension (OLE) study in pulmonary arterial hypertension (PAH). Learn more: bit.ly/4bJeWgw
2
672
Connect with us at the @GoldmanSachs 47th Annual Global Healthcare Conference to hear more about our science and its potential for patients and their families.
Insmed to present at Goldman Sachs Healthcare Conference.

ALT Insmed to present at Goldman Sachs Healthcare Conference.

1
269
Join us for our session at #ATS2026 with Colin Swenson, MD, to learn how bronchiectasis symptoms may contribute to underdiagnosis and how to recognize them.
Closing the Diagnostic Gap in Bronchiectasis: A Practical Approach

ALT Closing the Diagnostic Gap in Bronchiectasis: A Practical Approach

2
311
Come down to booth 937 during #ATS2026 to learn how we’re committed to helping support patients with serious respiratory diseases.
Insmed to attend ATS 2026, booth 937.

ALT Insmed to attend ATS 2026, booth 937.

1
2
764
Today we reported our 2026 Q1 earnings. Watch below to see some of the highlights and read more here: bit.ly/insmed-q1-2026-result… $INSM
2
683
We're getting excited for #ATS2026. We’ll be sharing six abstracts highlighting key focus areas to support patients. Learn more: bit.ly/4f0uI9j

1
2
796
Join us at the @BankofAmerica Securities 2026 Healthcare Conference and 2026 @rbccm Global Healthcare Conference to hear how we’re working to help reimagine the future for patients with serious diseases.
Upcoming conferences for Insmed.

ALT Upcoming conferences for Insmed.

1
180
We’re focused on serving patient communities where there is unmet need. We reported positive topline results from our Phase 3b study in diagnosed patients with a new occurrence of MAC lung infection who have not received antibiotics. Read more: bit.ly/4dCkxqH
3
5
435
Our Q4 and full-year 2025 earnings demonstrate the significant progress we made to advance our business and support patients around the world. $INSM
1
5
796
Load more